Adverse effects of antiretrovirals in HIV-infected pregnant women

Annals of Pharmacotherapy

Volumn 43, Issue 6, 2009, Pages 1028-1035

  Zuk, Dalyce M ^a   Hughes, Christine A ^b,c   Foisy, Michelle Marie ^c   Robinson, Joan L ^b   Singh, Ameeta E ^b   Houston, Stan ^b  

^a Capital Health Edmonton   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c ALBERTA HEALTH SERVICES   (Canada)

Author keywords

Adverse effects; Antiretroviral therapy; HIV; Pregnancy

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; ANEMIA; ARTICLE; BODY WEIGHT; CENTRAL NERVOUS SYSTEM DISEASE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DELIVERY; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG ERUPTION; DYSPEPSIA; FEMALE; GASTROINTESTINAL SYMPTOM; GESTATIONAL AGE; HEADACHE; HEPATITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LACTIC ACIDOSIS; LIVER TOXICITY; MAJOR CLINICAL STUDY; MONOTHERAPY; MORBIDITY; NAUSEA; PANCREATITIS; PATIENT MONITORING; PHYSICAL EXAMINATION; PREGNANT WOMAN; PRIORITY JOURNAL; PROBABILITY; SELF REPORT; SIDE EFFECT; SKIN MANIFESTATION; SKIN PRURITUS; VOMITING;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; DRUG MONITORING; FEMALE; HIV INFECTIONS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 67249155749     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L689     Document Type: Article

References (18)

1. Perinatal HIV Guidelines Working Group. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. July 8, 2008:1-98. http://aidsinfo.nih.gov/ContentFIles/ PerinatlaGL.pdf (accessed 2008 Oct 15).
2. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. January 29, 2008; 1-128. www.aidsinfo.nih.gov.ContentFiles/AdultandAdolescentGL.pdf. (accessed 2008 Oct 15).
3. Hughes CA, Zuk D, Foisy M, Robinson J, Singh AE, Houston S. Prenatal screening and perinatal HIV transmission in Northern Alberta, 1999-2006. Epub 16 Apr 2009. Am J Public Health.
4. Toxicity severity grading scale (modified from the AIDS Clinical Trials Group) San Diego, CA: Agouron Pharmaceuticals, March 1997.
5. Laboratory changes grading scale (modified from the AIDS Clinical Trials Group) San Diego, CA: Agouron Pharmaceuticals, March 1997.
6. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-245
7. Lyons F, Hopkins S, Kelleher B, et al. Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy. HIV Medicine 2006;7:255-260
8. Marazzi MC, Germano P, Liotta G, et al. Safety of nevirapine-containing antiretroviral triple therapy regimens to prevent vertical transmission in an African cohort of HIV-1-infected pregnant women. HIV Medicine 2006;7:338-344 (Pubitemid 43805695)
9. Hitti J, Frenkel LM, Stek AM, et al. Maternal toxicity with continuous nevirapine in pregnancy. J Acquir Immune Defic Syndr 2004;36:772-776
10. Timmermans S, Tempelman C, Godfried MH, et al. Nelfinavir and nevirapine side effects during pregnancy. AIDS 2005;19:795-799 (Pubitemid 40834749)
11. Sarner L, Fakoya A. Acute onset lactic acidosis and pancreatitis in the third trimester of pregnancy in HIV-1 positive women taking antiretroviral medication. Sex Transm Inf 2002;78:58-59 (Pubitemid 34206317)
12. Mandelbrot A, Lafanechere A, Longuet P, et al. Case report: nucleoside analogue-induced lactic acidosis in the third trimester of pregnancy. AIDS 2003;17:272-273 (Pubitemid 36183059)
13. Luzzati R, Del Bravo P, Di Perri G, Luzzani A, Concia E. Riboflavine and severe lactic acidosis. Lancet 1999;353:901-902
14. Watts H. Treating HIV during pregnancy: an update on safety issues. Drug Saf 2006;29:467-490 (Pubitemid 43855080)
15. Zhang J, Troendle J, Meikle S, Klebanoff MA, Rayburn WF. Isolated oligohydramnios is not associated with adverse perinatal outcomes. BJOG 2004;111:220-225 (Pubitemid 38299585)
16. Morris AB, Dobles AR, Cu-uvin S, et al. Protease inhibitor use in 233 pregnancies. J Acquir Immune Defic Syndr 2005;40:30-33 (Pubitemid 41233201)
17. Tuomala RE, Shapiro DE, Mofenson LM, et al. Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med 2002;346:1863-1870 (Pubitemid 34603030)
18. Cotter AM, Garcia AG, Duthely ML, Luke B, O'Sullivan MJ. Is antiretroviral therapy during pregnancy associated with an increased risk of preterm delivery, low birth weight, or stillbirth? J Infect Dis 2006;193:1195-1201